COST-EFFECTIVENESS ANALYSIS OF ADDING TUMOR TREATING FIELDS THERAPY TO TEMOZOLOMIDE VERSUS TEMOZOLOMIDE ONLY IN PATIENTS WITH GLIOBLASTOMA IN FRANCE

被引:0
|
作者
Guzman, Nino de Rivera J. [1 ]
Borgel, J. [2 ]
Chavez, G. [3 ]
Puc, C. [2 ]
Indukuri, N. [3 ]
Koh, C. Y. C. [4 ]
Poignant, P. [5 ]
Duteil, E. [5 ]
Gerves-Pinquie, C. [6 ]
Leproust, S. [5 ]
机构
[1] Novocure Glendale, Glendale, CO USA
[2] Novocure, Paris, France
[3] Novocure Inc, Brentwood, TN USA
[4] Novocure Inc, Portsmouth, NH USA
[5] IQVIA, Paris, France
[6] IQVIA, La Def, France
关键词
D O I
暂无
中图分类号
F [经济];
学科分类号
02 ;
摘要
EE363
引用
收藏
页码:S121 / S121
页数:1
相关论文
共 50 条
  • [41] Scalp-Sparing Radiation With Concurrent Temozolomide and Tumor Treating Fields (SPARE) for Patients With Newly Diagnosed Glioblastoma
    Miller, Ryan
    Song, Andrew
    Ali, Ayesha
    Niazi, Muneeb
    Bar-Ad, Voichita
    Martinez, Nina
    Glass, Jon
    Alnahhas, Iyad
    Andrews, David
    Judy, Kevin
    Evans, James
    Farrell, Christopher
    Werner-Wasik, Maria
    Chervoneva, Inna
    Ly, Michele
    Palmer, Joshua
    Liu, Haisong
    Shi, Wenyin
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [42] TUMOR TREATING FIELDS (TTFIELDS) IN COMBINATION WITH LOMUSTINE (CCNU) AND TEMOZOLOMIDE (TMZ) IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (GBM)
    Lazaridis, L.
    Schaefer, N.
    Kebir, S.
    Weller, J.
    Tzaridis, T.
    Schaeffler, B.
    Pierscianek, D.
    Kleinschnitz, C.
    Stuschke, M.
    Sure, U.
    Herrlinger, U.
    Glas, M.
    NEURO-ONCOLOGY, 2018, 20 : 230 - 230
  • [43] A PHASE II STUDY OF TUMOR TREATING FIELDS IN COMBINATION WITH BEVACIZUMAB AND TEMOZOLOMIDE IN PATIENTS WITH NEWLY DIAGNOSED, UNRESECTABLE GLIOBLASTOMA
    Sumrall, Ashley
    Haggstrom, Daniel
    Burri, Stuart
    Symanowski, James
    NEURO-ONCOLOGY, 2017, 19 : 16 - 16
  • [44] APPLICATION OF RTOG-RPA SCORES IN A PHASE 3 TRIAL OF TUMOR TREATING FIELDS WITH TEMOZOLOMIDE (TTFIELDS/TMZ) VERSUS TEMOZOLOMIDE (TMZ) ALONE IN NEWLY DIAGNOSED GLIOBLASTOMA
    Choe, Kevin
    Idbaih, Ahmed
    Taillibert, Sophie
    Escuder, Jordi Bruna
    Sroubek, Jan
    Kanner, Andrew
    NEURO-ONCOLOGY, 2017, 19 : 8 - 9
  • [45] Estimated Increase in Mean Lifetime Survival for Glioblastoma Patients Age 65 Years and Older Treated with Tumor Treating Fields and Temozolomide Compared to Patients Treated with Temozolomide Alone
    Guzauskas, G. F.
    Pollom, E.
    Wang, B. C. M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : E244 - E245
  • [46] Phase 1 study of concomitant tumor treating fields and temozolomide chemoradiation for newly diagnosed glioblastoma
    Goldlust, Samuel A.
    Singer, Samuel
    Cappello, Lori A.
    AlMekkawi, Ahmad K.
    Lee, Kangmin D.
    Ingenito, Anthony C.
    Lewis, Brett E.
    Nyirenda, Themba
    Azmi, Hooman
    Kaptain, George J.
    NEURO-ONCOLOGY ADVANCES, 2024, 6 (01)
  • [47] Triple-drug Therapy With Bevacizumab, Irinotecan, and Temozolomide Plus Tumor Treating Fields for Recurrent Glioblastoma: A Retrospective Study
    Lu, Guangrong
    Rao, Mayank
    Zhu, Ping
    Liang, Buqing
    El-Nazer, Rasheda T.
    Fonkem, Ekokobe
    Bhattacharjee, Meenakshi B.
    Zhu, Jay-Jiguang
    FRONTIERS IN NEUROLOGY, 2019, 10
  • [48] Tumour Treating Fields (TTFields) in combination with lomustine and temozolomide in patients with newly diagnosed glioblastoma
    Lazaros Lazaridis
    Niklas Schäfer
    Sarah Teuber-Hanselmann
    Tobias Blau
    Teresa Schmidt
    Christoph Oster
    Johannes Weller
    Theophilos Tzaridis
    Daniela Pierscianek
    Kathy Keyvani
    Christoph Kleinschnitz
    Martin Stuschke
    Björn Scheffler
    Cornelius Deuschl
    Ulrich Sure
    Ulrich Herrlinger
    Sied Kebir
    Martin Glas
    Journal of Cancer Research and Clinical Oncology, 2020, 146 : 787 - 792
  • [49] APPLYING TUMOR TREATING FIELDS (TTFIELDS) FOR ENHANCEMENT OF TEMOZOLOMIDE AND LOMUSTINE EFFICACY IN GLIOBLASTOMA CELL LINES
    Fishman, H.
    Monin, R.
    Dor-On, E.
    Kinzel, A.
    Haber, A.
    Giladi, M.
    Weinberg, U.
    Palti, Y.
    NEURO-ONCOLOGY, 2023, 25 : 63 - 63
  • [50] Tumour Treating Fields (TTFields) in combination with lomustine and temozolomide in patients with newly diagnosed glioblastoma
    Lazaridis, Lazaros
    Schaefer, Niklas
    Teuber-Hanselmann, Sarah
    Blau, Tobias
    Schmidt, Teresa
    Oster, Christoph
    Weller, Johannes
    Tzaridis, Theophilos
    Pierscianek, Daniela
    Keyvani, Kathy
    Kleinschnitz, Christoph
    Stuschke, Martin
    Scheffler, Bjoern
    Deuschl, Cornelius
    Sure, Ulrich
    Herrlinger, Ulrich
    Kebir, Sied
    Glas, Martin
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2020, 146 (03) : 787 - 792